Inhibition of Hepatocellular Carcinoma by Metabolic Normalization

PLoS ONE - United States
doi 10.1371/journal.pone.0218186
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Enzymatic Inhibition of MICA Sheddase ADAM17 by Lomofungin in Hepatocellular Carcinoma Cells

International Journal of Cancer
Cancer ResearchOncology
2018English

Inhibition of VEGF165/VEGFR2-dependent Signaling by LECT2 Suppresses Hepatocellular Carcinoma Angiogenesis

Scientific Reports
Multidisciplinary
2016English

Hormonal Control of the Metabolic Machinery of Hepatocellular Carcinoma

HepatoBiliary Surgery and Nutrition
2016English

Metabolic Syndrome-Associated Hepatocellular Carcinoma: Questions Still Unanswered

Journal of Hepatology
Hepatology
2015English

Growth Inhibition and Apoptosis Induction by (+)-Cyanidan-3-Ol in Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2013English

Exploring Metabolic Consequences of CPS1 and CAD Dysregulation in Hepatocellular Carcinoma by Network Reconstruction

Journal of Hepatocellular Carcinoma
2020English

Inhibition of WNT/Β-Catenin Signaling in Hepatocellular Carcinoma by an Antipsychotic Drug Pimozide

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2016English

Preferential Inhibition of Hepatocellular Carcinoma by the Flavonoid Baicalein Through Blocking MEK-ERK Signaling

International Journal of Oncology
Cancer ResearchOncology
2012English

Inhibition of Cell Proliferation and Metastasis of Human Hepatocellular Carcinoma by miR-137 Is Regulated by CDC42

Oncology Reports
MedicineCancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy